Well the Renasas IP deal has me excited and intrigued what the IP would be used for.
Using my advanced dot joining skills I have only come up with extreme left field possibilities.
However, all roads seem to lead to Toyota.
The wild dot joining has led me to Stradvision who are in collaboration with Socionext and Renasas (for Toyota through Denso) to develop a SoC for ADAS/AV and the teaser is Stradvision algorithms can be tuned to any hardware and are focused on sensor fusion for ADAS/AV In an interview with their CEO he mentioned the use of sparsity and quantization using tensorlite to run their algorithms on a Jetson. Now a SoC using Akida IP wouldn't need the Jetson and would lap up the quantization and sparsity and make the algorithm work even faster no need for accelerators
Long Bow I know but all happened around the time Socionext finished the Akida product
These Japanese companies seem all related Toyota Denso Renasas and have been putting capital into Stradvision
Adds to the mystery
- Forums
- ASX - By Stock
- BRN
- BRN Podcast
BRN Podcast, page-165
-
- There are more pages in this discussion • 766 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.8¢ |
Change
-0.003(1.25%) |
Mkt cap ! $366.5M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $761.1K | 3.771M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
86 | 1425290 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 716465 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
87 | 1429903 | 0.195 |
58 | 1574521 | 0.190 |
31 | 1283131 | 0.185 |
53 | 1543743 | 0.180 |
17 | 632162 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 713074 | 26 |
0.205 | 954646 | 21 |
0.210 | 1432297 | 27 |
0.215 | 536730 | 24 |
0.220 | 758461 | 24 |
Last trade - 14.46pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online